These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 33940943)

  • 1. Restoration of Noradrenergic Function in Parkinson's Disease Model Mice.
    Cui K; Yang F; Tufan T; Raza MU; Zhan Y; Fan Y; Zeng F; Brown RW; Price JB; Jones TC; Miller GW; Zhu MY
    ASN Neuro; 2021; 13():17590914211009730. PubMed ID: 33940943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
    Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine β-hydroxylase in adult rat brains.
    Fan Y; Huang J; Duffourc M; Kao RL; Ordway GA; Huang R; Zhu MY
    Neuroscience; 2011 Sep; 192():37-53. PubMed ID: 21763404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factors Phox2a/2b Upregulate Expression of Noradrenergic and Dopaminergic Phenotypes in Aged Rat Brains.
    Fan Y; Zeng F; Brown RW; Price JB; Jones TC; Zhu MY
    Neurotox Res; 2020 Oct; 38(3):793-807. PubMed ID: 32617854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine beta-hydroxylase in the locus coeruleus and adrenal glands of rats.
    Zhu MY; Wang WP; Iyo AH; Ordway GA; Kim KS
    J Neurochem; 2005 Aug; 94(3):828-38. PubMed ID: 16033425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress.
    Serova LI; Nankova BB; Feng Z; Hong JS; Hutt M; Sabban EL
    Biol Psychiatry; 1999 Apr; 45(7):853-62. PubMed ID: 10202573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease.
    Farrand AQ; Verner RS; McGuire RM; Helke KL; Hinson VK; Boger HA
    Brain Stimul; 2020; 13(5):1323-1332. PubMed ID: 32629028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosterone administration up-regulated expression of norepinephrine transporter and dopamine β-hydroxylase in rat locus coeruleus and its terminal regions.
    Fan Y; Chen P; Li Y; Cui K; Noel DM; Cummins ED; Peterson DJ; Brown RW; Zhu MY
    J Neurochem; 2014 Feb; 128(3):445-58. PubMed ID: 24111919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transcription factors Phox2 on expression of norepinephrine transporter and dopamine beta-hydroxylase in SK-N-BE(2)C cells.
    Fan Y; Huang J; Kieran N; Zhu MY
    J Neurochem; 2009 Sep; 110(5):1502-13. PubMed ID: 19573018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats.
    Rusnák M; Kvetnanský R; Jeloková J; Palkovits M
    Brain Res; 2001 Apr; 899(1-2):20-35. PubMed ID: 11311864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.
    Sugama S; Sekiyama K; Kodama T; Takamatsu Y; Takenouchi T; Hashimoto M; Bruno C; Kakinuma Y
    Brain Behav Immun; 2016 Jan; 51():39-46. PubMed ID: 26291405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus coeruleus is involved in weight loss in a rat model of Parkinson's disease: an effect reversed by deep brain stimulation.
    Guimarães J; Moura E; Silva E; Aguiar P; Garrett C; Vieira-Coelho MA
    Brain Stimul; 2013 Nov; 6(6):845-55. PubMed ID: 23849716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of endogenous amyloid-β to the coeruleo-cortical pathway: consequences of noradrenergic depletion.
    Ross JA; Reyes BAS; Thomas SA; Van Bockstaele EJ
    Brain Struct Funct; 2018 Jan; 223(1):267-284. PubMed ID: 28779307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice.
    Ross JA; Alexis R; Reyes BAS; Risbrough V; Van Bockstaele EJ
    Brain Struct Funct; 2019 Sep; 224(7):2385-2405. PubMed ID: 31250157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase a knock out mice.
    Zhang J; Darling RD; Paul IA; Simpson KL; Chen K; Shih JC; Lin RC
    Anat Rec (Hoboken); 2011 Oct; 294(10):1685-97. PubMed ID: 21901841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.